Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesHypothyroidism
U.S. Pharmacist, 10/07/09
Freeman G et al. – Hypothyroidism is a chronic condition that afflicts millions of Americans. Proper and timely diagnosis, along with correct treatment, can go a long way toward reducing the morbidity and mortality associated with this disease state. Measurement of TSH and T4 blood concentrations remains the standard method of diagnosis. Levothyroxine is the current treatment of choice; when used correctly, it alleviates the signs and symptoms of hypothyroidism.
Related Articles
Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Relevance Score: 88%
Relationship between age and serum thyrotropin among asymptomatic older people in Taiwan
Archives of Gerontology and Geriatrics, 10/19/09
Relevance Score: 85%
More hypothyroidism and less hyperthyroidism with sufficient iodine nutrition compared to mild iodine deficiency-A comparative population-based study of older people
Maturitas, 10/16/09
Relevance Score: 85%
Subclinical Hypothyroidism in Korean Preterm Infants Associated with High Levels of Iodine in Breast Milk
Journal of Clinical Endocrinology and Metabolism, 10/14/09
Relevance Score: 85%
Can Quetiapine-Induced Hypothyroidism be Reversible Without Quetiapine Discontinuation
Clinical Neuropharmacology, 10/13/09
Relevance Score: 85%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09
Inflammatory breast cancer: what are the treatment options
Expert Opinion in Pharmacotherapy, 12/08/09
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
Expert Opinion on Investigational Drugs, 12/08/09
Sponsor
Article Search
Sponsor